hero section gradient
2 handpicked stocks

India's 2025 Growth Playbook

Get ahead with stocks positioned to benefit from India's massive economic push. These companies are set to capture gains from the government's record infrastructure spending, financial expansion, and consumer tax cuts designed to drive the world's fastest-growing major economy.

Author avatar

Han Tan | Market Analyst

Published on July 1

Your Basket's Financial Footprint

Brief interpretation of the basket's market capitalisation and investor implications.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking to broader market performance, reducing idiosyncratic risk.
  • Treat this basket as a core holding for diversified exposure rather than a speculative, high-growth trade.
  • Expect steadier, long-term appreciation rather than explosive short-term gains; returns tend to be gradual.
Total Market Cap
  • HDB: $175.93B

  • IBN: $112.15B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection targets companies directly benefiting from India's three-pronged growth strategy for 2025. With record capital spending on infrastructure, expanded financial services, and tax cuts to boost consumer spending, these stocks are positioned at the center of what's projected to be the world's fastest-growing major economy.

2

What You Need to Know

These stocks represent market leaders across key sectors driving India's domestic growth - from construction firms building public infrastructure to banks facilitating credit expansion and consumer companies capturing increased household spending. They're specifically selected to benefit from the government's coordinated fiscal stimulus.

3

Why These Stocks

Each company was carefully selected for its position as a primary beneficiary of India's strategic economic plan. These are established market leaders with the scale and capabilities to secure government contracts, capitalize on increased liquidity, or capture rising consumer demand triggered by the stimulus program.

Why You'll Want to Watch These Stocks

🚀

Riding the World's Fastest-Growing Economy

India is projected to outpace all other major economies in 2025. These companies are strategically positioned at the center of this growth surge, with potential to deliver significant returns as the stimulus takes effect.

💰

Tax Cuts Unleashing Consumer Spending

With middle-income tax cuts putting more money in consumers' pockets, companies in this group focusing on automotive, retail, and consumer goods are poised to see surging sales and expanding profits.

🏗️

Record Infrastructure Investment Flowing

The government's unprecedented capital expenditure plan is directing billions toward construction, engineering, and infrastructure projects. These handpicked companies are first in line to secure these lucrative contracts.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions